top of page

De Quervain's Tenosynovitis Injection: Ultrasound-Guided First Dorsal Compartment Injection Technique


If you've been managing De Quervain's tenosynovitis in your clinic, you already know how frustrating it can be — both for the patient and for the treating physician. Conservative treatment helps many, but a significant number of patients continue to have pain that interferes with daily activities. When that happens, a corticosteroid injection into the first dorsal compartment is often the next step.

The question is: are you injecting accurately?

Landmark-based injections for De Quervain's have a surprisingly variable success rate. Cadaveric studies have shown that a significant proportion of blind injections miss the tendon sheath entirely, landing in peritendinous tissue rather than where the medication needs to go. Ultrasound guidance changes that equation considerably — and in this post, we walk through the technique exactly as demonstrated in the Asian Pain Academy procedural video.


Why Ultrasound-Guided De Quervain's Injection Is the Standard You Should Be Using


The first dorsal compartment is a small, confined space. It contains the abductor pollicis longus (APL) and extensor pollicis brevis (EPB) tendons, enclosed within a fibro-osseous sheath that sits just over the radial styloid. The sheath is tight, the tendons are superficial, and there's a structure you absolutely do not want to touch sitting right nearby — the superficial branch of the radial nerve.

With a landmark-based approach, you're working blind in a space where the margin for error is narrow. Ultrasound lets you see the sheath, confirm needle placement, watch the injectate spread around the tendons in real time, and avoid the radial nerve. That's not a small advantage — it's the difference between a procedure done and a procedure done correctly.

There's also the issue of subcompartments. A significant percentage of patients have a septum dividing the APL and EPB into separate compartments within the first dorsal compartment. If you inject into one and miss the other, the patient gets partial relief at best and comes back thinking the injection didn't work. Ultrasound lets you identify this anatomical variation before you inject and plan accordingly.


Patient Selection: Who Needs This Procedure

The ultrasound-guided injection for De Quervain's tenosynovitis is indicated when:

  • The patient has pain and tenderness over the radial styloid, aggravated by thumb and wrist movement

  • The Finkelstein test is positive — the patient makes a fist with the thumb inside, and ulnar deviation of the wrist reproduces or significantly worsens the pain

  • Activities of daily life are being affected — writing, gripping, lifting, even holding a phone

  • Conservative treatment has been attempted and has not provided adequate relief — this typically means a period of activity modification, splinting, and NSAIDs

It's worth noting that the Eichhoff test (often confused with the Finkelstein test) is slightly different in execution. The classic Finkelstein maneuver involves the examiner gripping the thumb and performing the ulnar deviation passively. Both are clinically useful, but it's good practice to be precise about what you're testing and documenting.

On ultrasound before the injection, you'll typically see thickening of the tendon sheath, reduced echogenicity of the tendons, and sometimes fluid within the sheath. Power Doppler may show increased vascularity consistent with active tenosynovitis.


Equipment and Preparation


Probe selection: Use a high-frequency linear transducer — typically 12 MHz or higher. The structures you're imaging are superficial, and a high-frequency probe gives you the resolution needed to clearly differentiate the APL from the EPB and visualize the overlying retinaculum.


Needle: A 25 or 26-gauge needle, 1.5 inches, works well for most patients. The superficial location of the sheath means you don't need anything longer.


Injectate: The standard preparation is a low-volume combination of a corticosteroid and local anaesthetic. Keeping the volume low — typically 1 to 1.5 mL — is important in a confined sheath. You want to spread around the tendons, not distension that causes pressure pain.


Sterile preparation: Standard procedural prep applies — skin cleaning, sterile gel or probe cover depending on your setup, and sterile gloves.


Step-by-Step Ultrasound-Guided Injection Technique for the First Dorsal Compartment


Step 1: Position the Patient and Probe

Position the patient with the forearm in a neutral position, thumb pointing upward, and the wrist slightly ulnar deviated. This relaxes the tendons and opens up the compartment slightly.

Place the high-frequency linear probe transversely over the radial styloid. In this orientation, you'll see the APL and EPB tendons in cross-section — appearing as oval or round hyperechoic structures sitting in a groove just lateral to the radial styloid. The fibrous retinaculum overlies them as a thin bright line.

Take your time with this step. Identify both tendons individually. Note whether there is a septum between them — if there is, you may need to inject both subcompartments separately. Identify the superficial branch of the radial nerve, which typically runs just superficial and slightly lateral — this is the structure you must consciously avoid throughout the procedure.


Step 2: Plan Your Needle Path

APA's procedural video demonstrates an in-plane needle approach, which means the needle travels along the long axis of the probe and is visible along its full length throughout the procedure. This is the recommended approach for this injection — it allows you to see the needle tip at all times, which is non-negotiable when you're working this close to the radial nerve.

You can approach from lateral to medial or medial to lateral depending on your preference and the patient's anatomy. The lateral approach is commonly used, advancing the needle from the radial side toward the tendon sheath.


Step 3: Advance the Needle Under Continuous Visualization

Insert the needle in-plane and advance slowly toward the tendon sheath under continuous real-time ultrasound guidance. You're aiming to enter the sheath — the space between the retinaculum and the tendon surface — not the substance of the tendon itself.

Always keep the needle tip visible. If you lose sight of it, stop. Rotating the needle slightly or adjusting the probe angle can help bring the tip back into view. Never advance a needle you cannot see.


Step 4: Confirm Position and Inject

Before injecting the full volume, give a small test injection — just enough to confirm needle placement. Watch the ultrasound screen carefully.

If the position is correct: You will see the injectate spreading around the tendons within the sheath — a characteristic anechoic or hypoechoic halo forming around the tendon cross-sections. This is what you're looking for.

If the position is incorrect: The fluid will not spread in this pattern. You might see a focal bleb forming at the needle tip without sheath distension, or no visible spread at all. If this happens, reposition the needle. Do not inject the full volume into an incorrectly positioned needle — you'll be depositing corticosteroid into peritendinous tissue, which is less effective and increases the risk of subcutaneous fat atrophy and skin depigmentation.

Once sheath placement is confirmed, inject the remainder of the medication slowly and steadily, watching the spread throughout.


Step 5: Nerve Avoidance and Post-Procedure Care

Throughout the procedure, maintain awareness of the superficial branch of the radial nerve. It's a small structure that can be difficult to see consistently, but identifying it before you begin and keeping your needle path clear of it is essential. Inadvertent injection near this nerve can cause temporary paresthesia or, in rare cases, more prolonged nerve irritation.

After the injection, apply gentle pressure to the site, advise the patient to rest the wrist for the remainder of the day, and counsel them on the expected timeline for response — most patients notice improvement within a few days, with maximum effect at two to three weeks.


A Note on Subcompartment Anatomy

This deserves a dedicated mention because it's clinically relevant and frequently missed in non-ultrasound-guided practice.

Studies have reported that anywhere from 20% to over 50% of individuals have a fibrous septum separating the APL and EPB into distinct subcompartments within the first dorsal compartment. If you inject into the APL sheath but the EPB has its own separate compartment, the EPB remains uninflected and the patient's pain from EPB tenosynovitis persists.

On ultrasound, you can identify this septum as a thin echogenic line running between the two tendons. If you see it, plan a two-point injection — one for each subcompartment — and adjust your volume accordingly. This simple step significantly improves outcomes in patients with this anatomical variant.


Why Visualization Changes the Outcome

The core principle behind every ultrasound-guided procedure is this: you inject what you can see, and you avoid what you can see. For De Quervain's tenosynovitis, this translates directly into better outcomes — higher rates of symptom relief, fewer repeat injections, and a reduced risk of complications like tendon rupture or skin changes from misdirected corticosteroid.

It also makes you a more confident clinician. When you watch the injectate spread smoothly around both tendons in real time and confirm correct placement before depositing the medication, you walk away from the procedure knowing it was done properly. That certainty matters.


FAQs: Ultrasound-Guided De Quervain's Injection


1. What is the success rate of ultrasound-guided injection for De Quervain's tenosynovitis compared to blind injection? Ultrasound-guided injections demonstrate significantly higher accuracy of intra-sheath placement compared to landmark-based techniques. Multiple studies have shown that blind injections miss the sheath in a substantial proportion of cases. Accurate intra-sheath placement is directly associated with better clinical outcomes and longer duration of relief.


2. Which corticosteroid is preferred for De Quervain's injection, and what volume should be used? Triamcinolone acetonide and methylprednisolone acetate are both commonly used. Volume should be kept low — typically 1 to 1.5 mL total — because the sheath is a confined space. Higher volumes increase the risk of pressure within the sheath and peritendinous leakage.


3. How many injections can be safely given for De Quervain's tenosynovitis? Most guidelines suggest limiting injections to two or three over a twelve-month period. Repeated corticosteroid injections into or near tendons carry a cumulative risk of tendon weakening and potential rupture. If adequate symptom control isn't achieved after two well-placed injections, surgical release should be discussed.


4. Can ultrasound identify subcompartments in the first dorsal compartment before injection? Yes — this is one of the key advantages of ultrasound guidance. A fibrous septum separating the APL and EPB subcompartments can be identified on high-frequency ultrasound before injection, allowing the operator to plan accordingly and inject both compartments if necessary. This is a major reason why ultrasound-guided injections outperform blind injections in patients who have failed previous landmark-based treatment.


5. What is the risk of injecting into the tendon substance rather than the sheath? Intra-tendinous corticosteroid injection is associated with a risk of tendon degeneration and rupture, particularly with repeated injections. Ultrasound guidance allows real-time visualization of the needle tip relative to the tendon, making it possible to confirm sheath placement and avoid intra-tendinous injection. If resistance is felt during injection, the needle should be repositioned before continuing.


6. How should the superficial branch of the radial nerve be identified and protected during this procedure? The superficial branch of the radial nerve runs superficially in the region of the first dorsal compartment and should be identified on ultrasound before needle insertion. An in-plane needle approach allows continuous visualization of the needle shaft and tip, which helps maintain a safe trajectory away from the nerve. Awareness of its location throughout the procedure is essential.


7. When should surgical release be considered over repeated injections? Surgical first dorsal compartment release is considered when a patient has failed two or more accurately performed injections, when anatomical variations make injection consistently difficult, or when the patient has a strong occupational or lifestyle need for definitive treatment. Surgery is generally effective, though ultrasound-guided injection remains the preferred first intervention when patient selection is appropriate.


8. Is this procedure suitable for pregnant patients with De Quervain's tenosynovitis? De Quervain's tenosynovitis is relatively common during and after pregnancy due to hormonal changes and new mechanical demands from infant care. Corticosteroid injections during pregnancy require careful consideration and should be discussed with the patient's obstetrician. Splinting and activity modification are typically the first line in this group, with injection reserved for cases where function is significantly impaired and the risk-benefit discussion supports it.


Learn Ultrasound-Guided Procedures Through Asian Pain Academy

The technique demonstrated in this video is part of a broader curriculum at Asian Pain Academy covering ultrasound-guided interventions across the full musculoskeletal system — from the shoulder and elbow through the wrist, hand, hip, knee, ankle, and foot, as well as spine-related procedures under C-arm guidance.

If you're a practicing clinician who wants to build or refine procedural skills in interventional pain medicine, APA offers structured fellowship programs — both 6-month and 1-year — with live interactive classes, recorded sessions, hands-on workshops in Kolkata, and optional clinical attachment.


Subscribe to the Asian Pain Academy YouTube channel for procedure demonstrations like this one, covering the full range of interventional techniques used in modern pain practice.

📞 +91 98304-48748 | +91 9830262733 📧 asianpainacademy@gmail.com 🌐


Asian Pain Academy | Kolkata, West Bengal | Accredited by the American Accreditation Association

Comments


Asian Pain Academy 

  • Facebook
  • Youtube
  • X
  • Instagram
  • Whatsapp

Contact No - +91 98304-48748 , 9830262733,  Email - asianpainacademy@gmail.com
Registered Office Address - AB-46, Street Number 89, Action Area 1A, Newtown, Kolkata, West Bengal 700163
Workshops will be conducted at 
Rajarhat PainClinic - Address: AB-46, Street Number 89, Action Area 1A, Newtown, Kolkata, West Bengal 700156
Samobathi  Pain Clinic - Address: 6/Z Umakanta Sen Lane, Kolkata, West Bengal 700030

© 2024 by Asian Pain Academy.

Frequently asked questions

bottom of page